Lebel, E.; Nachmias, B.; Pick, M.; Gross Even-Zohar, N.; Gatt, M.E.
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma. J. Clin. Med. 2022, 11, 1809.
https://doi.org/10.3390/jcm11071809
AMA Style
Lebel E, Nachmias B, Pick M, Gross Even-Zohar N, Gatt ME.
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma. Journal of Clinical Medicine. 2022; 11(7):1809.
https://doi.org/10.3390/jcm11071809
Chicago/Turabian Style
Lebel, Eyal, Boaz Nachmias, Marjorie Pick, Noa Gross Even-Zohar, and Moshe E. Gatt.
2022. "Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma" Journal of Clinical Medicine 11, no. 7: 1809.
https://doi.org/10.3390/jcm11071809
APA Style
Lebel, E., Nachmias, B., Pick, M., Gross Even-Zohar, N., & Gatt, M. E.
(2022). Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma. Journal of Clinical Medicine, 11(7), 1809.
https://doi.org/10.3390/jcm11071809